ELDN logo

Eledon Pharmaceuticals (ELDN)

Profile

Full Name

Eledon Pharmaceuticals, Inc.

Ticker Symbol

ELDN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 17, 2014

Indexes

Not included

Website

http://eledon.com

Employees

31

Key Details

Price

$3.00(0.00%)

Market cap

$179.65M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.75(+84.14% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.00
ELDN price is $3.00

30-Day Relative Volume

0.85
ELDN 30-day relative volume is 0.85

Price Performance

Price Today change

0%
ELDN {parameterFullLabel} is unchanged today

Price YTD change

-27.18%
ELDN price is down -27.18% since January 1st

Price 1-year change

+91.08%
ELDN price is up +91.08% year-on-year

Price 3-year change

-0.99%
ELDN price is down -0.99% over the past 3 years

Price Range

Price All-time high

$4860.00
ELDN price is currently -99.94% below its historical high of $4860.00

Price 3-year low

$1.07
ELDN price is currently +180.37% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$179.65M
ELDN market capitalization is $179.65 million

Market cap 3-year change

+330.98%
ELDN market capitalization is up +330.98% over the past 3 years

Market cap All-time high

$518.86M
ELDN market capitalization is currently -65.38% below its historical high of $518.86 million

Market cap sector rank

55.84%
ELDN market capitalization is higher than 55.84% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+141.33%
ELDN shares outstanding is up +141.33% year-on-year

Shares Outstanding 3-Year Change

+335.29%
ELDN shares outstanding is up +335.29% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.11
ELDN beta is 1.11

200-day SMA

$3.53
ELDN price is currently -15.06% below its 200-day simple moving average

50-day SMA

$3.74
ELDN price is currently -19.72% below its 50-day simple moving average

RSI

39.40
ELDN 14-day relative strength index is 39.40

Volume

0.85
ELDN 30-day relative volume is 0.85

ATR

$0.23
ELDN average true range is $0.23

10-day Historical Volatility

87.38%
ELDN 10-day historical volatility is 87.38%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
ELDN annual revenue value is unknown

Revenue Analysts estimate

-
ELDN annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
ELDN annual revenue 1-year change is unknown

Revenue Sector rank

-
ELDN annual revenue is unknown

EPS

EPS

-$0.75
ELDN annual earnings per share is -$0.75

EPS Analysts estimate

-$1.19
ELDN annual earnings per share is currently -36.84% lower than the consensus analysts' forecast

EPS 1-year change

+84.14%
ELDN annual earnings per share is up +84.14% year-on-year

EPS Sector rank

62.23%
ELDN annual earnings per share is higher than 62.23% of companies in Healthcare sector

Profit

Gross profit

-
ELDN annual gross profit value is unknown

Gross margin

-
ELDN annual gross profit margin value is unknown

Operating profit

-$70.58M
ELDN annual operating income is -$70.58 million

Operating margin

-
ELDN annual operating profit margin value is unknown

Net income

-$36.18M
ELDN annual net profit is -$36.18 million

Net margin

-
ELDN annual net profit margin value is unknown

Expenses

Total expenses

$70.58M
ELDN annual total expenses is $70.58 million

Operating expenses

$70.58M
ELDN annual total operating expenses is $70.58 million

Cost of goods sold

-
ELDN annual cost of goods sold value is unknown

Selling, general & administrative expenses

$18.61M
ELDN annual SGA is $18.61 million

Depreciation and amortization

$359.00K
ELDN annual depreciation & amortization is $359.00 thousand

Interest expense

-
ELDN annual interest expense value is unknown

Income tax

$431.00K
ELDN annual income tax is $431.00 thousand

EBIT & EBITDA

EBIT

-$70.58M
ELDN annual earnings before interest & taxes is -$70.58 million

EBITDA

-$70.22M
ELDN annual EBITDA is -$70.22 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$177.41M
ELDN annual total assets is $177.41 million

Non current assets

$33.67M
ELDN annual long term assets is $33.67 million

Current assets

$143.73M
ELDN annual total current assets is $143.73 million

Cash and cash equivalents

$20.55M
ELDN annual cash & cash equivalents is $20.55 million

Accounts receivable

-
ELDN annual accounts receivable value is unknown

Inventory

-
ELDN annual inventory value is unknown

Liabilities

Total liabilities

$59.27M
ELDN annual total liabilities is $59.27 million

Long term liabilities

$47.69M
ELDN annual total long term liabilities is $47.69 million

Current liabilities

$11.58M
ELDN annual total current liabilities is $11.58 million

Accounts payable

$5.83M
ELDN annual accounts payable is $5.83 million

Debt

Total debt

$954.00K
ELDN annual total debt is $954.00 thousand

Total debt 1-year change

+149.09%
ELDN annual total debt is up +149.09% year-on-year

Long term debt

$640.00K
ELDN annual long term debt is $640.00 thousand

Short term debt

$314.00K
ELDN annual short term debt is $314.00 thousand

Equity & Capital

Shareholders equity

$118.14M
ELDN annual stockholders equity is $118.14 million

Book value

$118.14M
ELDN annual book value is $118.14 million

Retained earnings

-$355.59M
ELDN annual retained earnings is -$355.59 million

Working capital

$132.15M
ELDN annual working capital is $132.15 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$47.27M
ELDN annual cash flow from operations is -$47.27 million

Cash from operations 1-year change

-19.59%
ELDN annual cash flow from operations is down -19.59% year-on-year

Cash from investing

-$70.31M
ELDN annual cash flow from investing activities is -$70.31 million

Cash from investing 1-year change

-55.26%
ELDN annual cash flow from investing activities is down -55.26% year-on-year

Cash from financing

$133.52M
ELDN annual cash flow from financing activities is $133.52 million

Cash from financing 1-year change

+304.4%
ELDN annual cash flow from financing activities is up +304.4% year-on-year

CAPEX

CAPEX

-
ELDN annual capital expenditures value is unknown

CAPEX 1-year change

-
ELDN annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$47.27M
ELDN annual free cash flow is -$47.27 million

Free cash flow 1-year change

-19.59%
ELDN annual free cash flow is down -19.59% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ELDN annual gross profit margin value is unknown

Operating margin

-
ELDN annual operating profit margin value is unknown

Net margin

-
ELDN annual net profit margin value is unknown

ROA & ROE

ROA

-20.40%
ELDN annual return on assets is -20.40%

ROE

-30.63%
ELDN annual return on equity is -30.63%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ELDN price to earnings ratio value is unknown

PE ratio Sector rank

-
ELDN price to earnings ratio is unknown

PB Ratio

PB ratio

1.52
ELDN price to book ratio is 1.52

PB ratio Sector rank

56.51%
ELDN price to book ratio is higher than 56.51% of companies in Healthcare sector

PS Ratio

PS ratio

-
ELDN price to sales ratio value is unknown

PS ratio Sector rank

-
ELDN price to sales ratio is unknown

Enterprise value

Enterprise value

$160.05M
ELDN enterprise value is $160.05 million

Enterprise value Sector rank

55.49%
ELDN enterprise value is higher than 55.49% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.28
ELDN EV/EBITDA is -2.28

EV/EBITDA Sector rank

29.91%
ELDN EV/EBITDA is higher than 29.91% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

12.42
ELDN annual current ratio is 12.42

Quick ratio

-
ELDN annual quick ratio value is unknown

Leverage

Debt to equity

0.01
ELDN annual debt to equity ratio is 0.01

Interest coverage ratio

-
ELDN annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ELDN piotroski f-score value is unknown

Altman Z-Score

-
ELDN altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Nov 20, 24 HC Wainwright & Co.
Buy
Jun 4, 24 HC Wainwright & Co.
Buy
May 10, 24 HC Wainwright & Co.
Buy
May 7, 24 HC Wainwright & Co.
Buy
Mar 22, 24 HC Wainwright & Co.
Buy
Nov 13, 23 HC Wainwright & Co.
Buy
Oct 24, 23 HC Wainwright & Co.
Buy
Sep 27, 23 Noble Capital Markets
Outperform
Aug 22, 23 Cantor Fitzgerald
Overweight
May 26, 23 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

TriSalus Life Sciences (TLSI)
HITI logo
High Tide (HITI)
LXRX logo
Lexicon Pharmaceuticals (LXRX)
TuHURA Biosciences (HURA)
DRTS logo
Alpha Tau Medical (DRTS)
INGN logo
Inogen (INGN)
MDWD logo
MediWound (MDWD)
CDXS logo
Codexis (CDXS)
GNFT logo
Genfit SA (GNFT)
  • What is the ticker symbol for Eledon Pharmaceuticals?
  • Does Eledon Pharmaceuticals pay dividends?
  • What sector is Eledon Pharmaceuticals in?
  • What industry is Eledon Pharmaceuticals in?
  • What country is Eledon Pharmaceuticals based in?
  • When did Eledon Pharmaceuticals go public?
  • Is Eledon Pharmaceuticals in the S&P 500?
  • Is Eledon Pharmaceuticals in the NASDAQ 100?
  • Is Eledon Pharmaceuticals in the Dow Jones?
  • When was Eledon Pharmaceuticals's last earnings report?
  • When does Eledon Pharmaceuticals report earnings?
  • Should I buy Eledon Pharmaceuticals stock now?

What is the ticker symbol for Eledon Pharmaceuticals?

The ticker symbol for Eledon Pharmaceuticals is NASDAQ:ELDN

Does Eledon Pharmaceuticals pay dividends?

No, Eledon Pharmaceuticals does not pay dividends

What sector is Eledon Pharmaceuticals in?

Eledon Pharmaceuticals is in the Healthcare sector

What industry is Eledon Pharmaceuticals in?

Eledon Pharmaceuticals is in the Biotechnology industry

What country is Eledon Pharmaceuticals based in?

Eledon Pharmaceuticals is headquartered in United States

When did Eledon Pharmaceuticals go public?

Eledon Pharmaceuticals's initial public offering (IPO) was on September 17, 2014

Is Eledon Pharmaceuticals in the S&P 500?

No, Eledon Pharmaceuticals is not included in the S&P 500 index

Is Eledon Pharmaceuticals in the NASDAQ 100?

No, Eledon Pharmaceuticals is not included in the NASDAQ 100 index

Is Eledon Pharmaceuticals in the Dow Jones?

No, Eledon Pharmaceuticals is not included in the Dow Jones index

When was Eledon Pharmaceuticals's last earnings report?

Eledon Pharmaceuticals's most recent earnings report was on Mar 20, 2025

When does Eledon Pharmaceuticals report earnings?

The next expected earnings date for Eledon Pharmaceuticals is May 9, 2025

Should I buy Eledon Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page